Page last updated: 2024-12-05

oxilofrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxilofrine: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID688009
CHEMBL ID1160695
CHEBI ID134822
SCHEMBL ID14153976
MeSH IDM0085979

Synonyms (51)

Synonym
carnigen
suprifene [french]
4-hydroxyephedrine
p-hydroxyephedrine
hydroxyephedrine
oxilofrinum [inn-latin]
einecs 206-672-3
oxilofrine [inn]
erythro-p-hydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol
methylsympatol
methylsynephrin
p-oxy-ephedrin [german]
oxyephedrin
oxyephedrine
oxilofrina [inn-spanish]
oxilofrine
(r*,s*)-4-hydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol
supriphen
4-hydroxy-alpha-(1-methylaminoethyl)benzylalkohol
benzyl alcohol, p-hydroxy-alpha-(1-(methylamino)ethyl)-
benzenemethanol, 4-hydroxy-alpha-(1-(methylamino)ethyl)-, (r*,s*)-
1-(4-hydroxyphenyl)-2-methylaminopropanol
oxilofrin
CHEBI:134822
methyl synephrine
j5.704e
methyl synephrin
edornat
methylsynephrine
4-[(1r,2s)-1-hydroxy-2-(methylamino)propyl]phenol
CHEMBL1160695
suprifene
f49638ubdr ,
oxilofrina
p-oxy-ephedrin
unii-f49638ubdr
oxilofrinum
erythro-p-hydroxy-.alpha.-(1-(methylamino)ethyl)benzyl alcohol
p-hydroxy-.alpha.-(1-(methylamino)ethyl)benzyl alcohol
(+/-)-p-hydroxyephedrine
.alpha.-(1-methylaminoethyl)-p-hydroxybenzyl alcohol
p-hydroxyephedrine [mi]
oxilofrine [who-dd]
benzenemethanol, 4-hydroxy-.alpha.-((1r)-1-(methylamino)ethyl)-, (.alpha.s)-rel-
rel-(.alpha.s)-4-hydroxy-.alpha.-((1r)-1-(methylamino)ethyl)benzenemethanol
SCHEMBL14153976
(r*,s*)-4-hydroxy-alpha-[1-(methylamino)ethyl]benzyl alcohol
4-hmp
DB11610
EN300-8141112
85482-66-2

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"In a combined pharmacokinetic and clinical trial the correlation was investigated between plasma levels of oxilofrine and the haemodynamic effects on eight healthy volunteers after an oral dose of 120 mg oxilofrine."( Clinical pharmacokinetics after a single oral dose of oxilofrine.
Angermann, C; Kauert, G; Lex, H; Spes, C, 1988
)
0.27

Dosage Studied

ExcerptRelevanceReference
"Single oral doses of 16, 32 and 64 mg oxilofrine as dragées as well as 16mg as drops were given to 12 healthy male volunteers in an open Latin-square design with one week interval between dosing days."( Dose linearity and relative bioavailability testing of oxilofrine, a sympathicomimetic drug, in healthy volunteers.
Kauert, G; Lorenz, H; Malerczyk, V; Verho, M, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkylbenzeneA monocyclic arene that is benzene substituted with one or more alkyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID70530Free energy of binding to turkey erythrocyte beta receptor1986Journal of medicinal chemistry, Feb, Volume: 29, Issue:2
Mapping the turkey erythrocyte beta receptor: a distance geometry approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (66.67)18.7374
1990's5 (13.89)18.2507
2000's0 (0.00)29.6817
2010's6 (16.67)24.3611
2020's1 (2.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (8.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (91.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]